Next Article in Journal
Formative Evaluation of Clinician Experience with Integrating Family History-Based Clinical Decision Support into Clinical Practice
Previous Article in Journal
Cardiovascular Disease Self-Management: Pilot Testing of an mHealth Healthy Eating Program
Article Menu

Export Article

Open AccessArticle
J. Pers. Med. 2014, 4(1), 102-114; doi:10.3390/jpm4010102

Diffusion of Molecular Diagnostic Lung Cancer Tests: A Survey of German Oncologists

ZS Associates International, Inc., Neue Mainzer Straße 28, 60311 Frankfurt, Germany
Received: 11 November 2013 / Revised: 2 March 2014 / Accepted: 4 March 2014 / Published: 21 March 2014
View Full-Text   |   Download PDF [493 KB, uploaded 21 March 2014]   |  


This study was aimed at examining the diffusion of diagnostic lung cancer tests in Germany. It was motivated by the high potential of detecting and targeting oncogenic drivers. Recognizing that the diffusion of diagnostic tests is a conditio sine qua non for the success of personalized lung cancer therapies, this study analyzed the diffusion of epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) tests in Germany. Qualitative and quantitative research strategies were combined in a mixed-method design. A literature review and subsequent Key Opinion Leader interviews identified a set of qualitative factors driving the diffusion process, which were then translated into an online survey. The survey was conducted among a sample of 961 oncologists (11.34% response rate). The responses were analyzed in a multiple linear regression which identified six statistically significant factors driving the diffusion of molecular diagnostic lung cancer tests: reimbursement, attitude towards R&D, information self-assessment, perceived attitudes of colleagues, age and test-pathway strategies. Besides the important role of adequate reimbursement and relevant guidelines, the results of this study suggest that an increasing usage of test-pathway strategies, especially in an office-based setting, can increase the diffusion of molecular diagnostic lung cancer tests in the future.
Keywords: diffusion of innovations; diagnostic tests; lung cancer diffusion of innovations; diagnostic tests; lung cancer
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Steffen, J.A. Diffusion of Molecular Diagnostic Lung Cancer Tests: A Survey of German Oncologists. J. Pers. Med. 2014, 4, 102-114.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
J. Pers. Med. EISSN 2075-4426 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top